Arsenal Capital Partners (“Arsenal”), a specialized private equity firm investing in healthcare and industrials companies, has completed the acquisition of Cello Health plc (“Cello Health”), the global healthcare-focused advisory firm, for a total enterprise value of £181.8 million. The acquisition of Cello Health provides the foundation for a new enterprise to enable healthcare and biopharmaceutical clients to maximize the value of their products. Through a series of investments to acquire, invest in and develop best-in-breed companies, the new enterprise that is backed by Arsenal is assembling a differentiated set of capabilities across critical domains including strategy and insights, evidence generation, data and analytics, and communications – all rooted in world-class science and enabled by the latest technology.
Read the full article: Arsenal Capital Partners Completes £182M Acquisition of Cello Health //
Source: https://www.prnewswire.com/news-releases/arsenal-capital-partners-completes-182-million-acquisition-of-cello-health-301109849.html